NMPA Approval

Recombinant Human Granulocyte Colony-stimulating Factor Injection

Approval Number

国药准字S20053010

Company成都生物制品研究所有限责任公司

Registration Date

February 25, 2020

Drug Information

Generic Name

重组人粒细胞刺激因子注射液

Trade Name

保力津

Dosage Form

注射剂(注射液)

Strength

300μg/1.2ml/瓶

Drug Type

生物制品

Registration Date

February 25, 2020

Company Information

Applicant Company

Company Name成都生物制品研究所有限责任公司

Manufacturing Company

Company Name成都生物制品研究所有限责任公司

Company Address

成都市锦江区锦华路三段379号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath